1. Home
  2. NPCE vs INDP Comparison

NPCE vs INDP Comparison

Compare NPCE & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$7.95

Market Cap

490.2M

Sector

Health Care

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

SELL

Current Price

$3.45

Market Cap

438.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NPCE
INDP
Founded
1997
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
490.2M
438.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NPCE
INDP
Price
$7.95
$3.45
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $14.11
N/A
AVG Volume (30 Days)
★ 376.2K
223.3K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.03
N/A
EPS
N/A
★ N/A
Revenue
★ $99,986,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.75
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 25.13
N/A
52 Week Low
$5.46
$0.92
52 Week High
$19.60
$5.96

Technical Indicators

Market Signals
Indicator
NPCE
INDP
Relative Strength Index (RSI) 23.99 57.88
Support Level N/A $2.17
Resistance Level $14.90 $3.71
Average True Range (ATR) 0.85 0.33
MACD -0.47 -0.01
Stochastic Oscillator 28.83 86.81

Price Performance

Historical Comparison
NPCE
INDP

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: